ClinicalTrials.Veeva

Menu

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes (PreciDIAB-H&B)

U

University Hospital, Lille

Status

Enrolling

Conditions

Cognitive Decline
Heart Failure
Diabetes Mellitus, Type 2

Study type

Observational

Funder types

Other

Identifiers

NCT04583800
2019_66
2020-A01452-37 (Other Identifier)

Details and patient eligibility

About

Type 2 diabetes is a risk factor of heart failure and cognitive decline. Heart failure at its early stage is often silent. At present, primary prevention for heart failure is not available. Our aim is to identify diabetic patients at risk of heart failure in order to develop personalized preventive strategies.

Type 2 diabetes is vascular and metabolic risk factor for cognitive decline though a direct lesional effect but also through an interaction with underlying neurodegenerative lesions. Our aim is to identify diabetic patients at risk of cognitive decline in order to develop personalized preventive strategies

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults
  • Persons able to understand and object to the information provided.
  • Type 2 diabetic patient free of heart failure ≥stade B
  • Patient affiliated with a social security scheme.
  • Patient agreeing to sign the informed consent form

Exclusion criteria

  • Patient with dementia
  • Patient with at least one of the criteria for heart failure ≥stade B

Trial contacts and locations

1

Loading...

Central trial contact

Charlotte Cordonnier, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems